Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 2
1988 1
1990 3
1991 5
1992 2
1993 5
1994 1
1995 2
1996 4
1997 5
1998 8
1999 8
2000 7
2001 10
2002 11
2003 7
2004 5
2005 6
2006 5
2007 6
2008 4
2009 2
2010 5
2011 4
2012 2
2013 4
2014 1
2015 3
2016 8
2017 2
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Results by year
Filters applied: . Clear all
Page 1
Nanosensors for cancer detection.
Huber F, Lang HP, Zhang J, Rimoldi D, Gerber C. Huber F, et al. Among authors: rimoldi d. Swiss Med Wkly. 2015 Feb 9;145:w14092. doi: 10.4414/smw.2015.14092. eCollection 2015. Swiss Med Wkly. 2015. PMID: 25664868 Free article. Review.
Melanoma-associated antigens.
Carrel S, Rimoldi D. Carrel S, et al. Among authors: rimoldi d. Eur J Cancer. 1993;29A(13):1903-7. doi: 10.1016/0959-8049(93)90548-t. Eur J Cancer. 1993. PMID: 8260252 Review. No abstract available.
Genomic and transcriptomic landscape of conjunctival melanoma.
Cisarova K, Folcher M, El Zaoui I, Pescini-Gobert R, Peter VG, Royer-Bertrand B, Zografos L, Schalenbourg A, Nicolas M, Rimoldi D, Leyvraz S, Riggi N, Moulin AP, Rivolta C. Cisarova K, et al. Among authors: rimoldi d. PLoS Genet. 2020 Dec 31;16(12):e1009201. doi: 10.1371/journal.pgen.1009201. eCollection 2020 Dec. PLoS Genet. 2020. PMID: 33383577 Free PMC article.
Conjunctival Melanoma Targeted Therapy: MAPK and PI3K/mTOR Pathways Inhibition.
El Zaoui I, Bucher M, Rimoldi D, Nicolas M, Kaya G, Pescini Gobert R, Bedoni N, Schalenbourg A, Sakina E, Zografos L, Leyvraz S, Riggi N, Rivolta C, Moulin AP. El Zaoui I, et al. Among authors: rimoldi d. Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2764-2772. doi: 10.1167/iovs.18-26508. Invest Ophthalmol Vis Sci. 2019. PMID: 31247083
Expression of CALLA/CD10 on human melanoma cells.
Carrel S, Zografos L, Schreyer M, Rimoldi D. Carrel S, et al. Among authors: rimoldi d. Melanoma Res. 1993 Oct;3(5):319-23. doi: 10.1097/00008390-199310000-00003. Melanoma Res. 1993. PMID: 8292887 Review.
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Romero P, Valmori D, Pittet MJ, Zippelius A, Rimoldi D, Lévy F, Dutoit V, Ayyoub M, Rubio-Godoy V, Michielin O, Guillaume P, Batard P, Luescher IF, Lejeune F, Liénard D, Rufer N, Dietrich PY, Speiser DE, Cerottini JC. Romero P, et al. Among authors: rimoldi d. Immunol Rev. 2002 Oct;188:81-96. doi: 10.1034/j.1600-065x.2002.18808.x. Immunol Rev. 2002. PMID: 12445283 Review.
Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells.
Neubert NJ, Tillé L, Barras D, Soneson C, Baumgaertner P, Rimoldi D, Gfeller D, Delorenzi M, Fuertes Marraco SA, Speiser DE. Neubert NJ, et al. Among authors: rimoldi d. Cancer Res. 2017 Apr 1;77(7):1623-1636. doi: 10.1158/0008-5472.CAN-16-2680. Epub 2017 Jan 19. Cancer Res. 2017. PMID: 28104684 Free article.
137 results